Docetaxel With or Without Vandetanib in Treating Patients With Metastatic Stomach Cancer or Gastroesophageal Junction Cancer

NCT00683787 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

8

Enrollment

OTHER

Sponsor class

Stopped low accrual

Conditions

Gastric Cancer

Interventions

DRUG: docetaxel
DRUG: vandetanib

Sponsor

Roswell Park Cancer Institute